The Foundation for Atopic Dermatitis, partner of Entretiens d’Avène, explains “Design Thinking in atopic dermatitis”: The patient at the heart of discussions
On December 2nd, 2017 the first training day for therapeutic patient education (TPE) was held at the Sainte-Justine Hospital in Montreal. The event focused on atopic dermatitis, and was chaired by Prof. Danielle Marcoux, dermatologist.
The role of intestinal dysbiosis is becoming clearer / Atopic dermatitis and cardiovascular risk / The parents are trustworthy...
ISAD 2016 : 9th Georg Rajka International Symposium on Atopic Dermatitis - May 19 - 21, 2016 - São Paulo (Brazil)Wed, 12/30/2015 - 17:27
The 9th edition of the symposium will be held in São Paulo, Brazil, and will be sponsored by the International Society of Atopic Dermatitis (ISAD), the Brazilian Atopic Dermatitis Association (AADA) and the Department of Dermatology of the University of São Paulo Medical School. Registration is by application only.
By Tuyet A. Nguyen, BS and Lawrence F. Eichenfield, MD
Rady Children’s Hospital, San Diego
Moisturizers continue to be an important adjunct therapy for a variety of dermatologic conditions.
As we learn more about skin barrier function and mechanisms leading to barrier dysfunction, new technologies lead the way in our search for the perfect moisturizer.
Bleomycin hydrolase downregulation in lesional skin of adult atopic dermatitis patients is independent of FLG gene mutationsFri, 04/03/2015 - 19:32
Atopic dermatitis (AD) pathogenesis is still incompletely understood. The major genetic risk factor is nonsense mutations of the FLG gene encoding filaggrin. 1 Filaggrin is a key protein for the stratum corneum (SC) barrier functions. 2,3 It is synthesized as a 400 kDa precursor named profilaggrin.
C. Méni, C. Bodemer, A. Toulon, S. Merhand, N. Perez-Cullell, S. Branchoux, C. Taieb
The Leuven Itch Scale (LIS). The LIS is an instrument to measure itch in patients experiencing pruritus of different origin. The novelty of the LIS, in contrast with several previously developed instruments, is that it approaches itch as a symptom, and that it consequently measures all aspects of that symptom: frequency, duration, severity, circumstances, treatment, consequences, sensory characteristics, distress and location(s).